Análisis del comportamiento del precio de los medicamentos para el tratamiento del cáncer por parte del sistema de seguridad social en salud para el periodo 1991 a 2013

Abstract

This paper is intended to conduct a pilot test of the behavior of prices in the medicine used to treat cancer, as there multinationals rise from two or more times the value thereof; compared to other countries in Latin America, producing an effect of slow death to patients and families facing discouragement to the impotence of the high costs of such treatments. It should be noted that in the effort to improve the conditions of patients in Colombia have created various collaborating institutions such is the case of the Mission Health Organisation which has analyzed the problems around the high price of drugs and expressed in their research that in the country that exceeds three to four times the world average prices, creating a huge taboo factor for the acquisition of a vital treatment in cancer patients (Colprensa, 2013).